Promising Phase 1 Results for DT-168 in Fuchs Endothelial Corneal Dystrophy
Design Therapeutics announced positive Phase 1 trial data for DT-168, an eye drop formulated to treat Fuchs endothelial corneal...
Anavex Life Sciences Announces Full Phase 2 Schizophrenia Study Enrollment
Anavex Life Sciences Corp. has completed enrollment in its Phase 2 clinical trial (ANAVEX3-71-SZ-001) of ANAVEX®3-71 for schizophrenia treatment....
BP1001-A Shows Promise as Obesity Treatment for Type 2 Diabetes
Bio-Path Holdings announced positive preclinical results for BP1001-A, a potential obesity and Type 2 diabetes treatment. The drug candidate...
Biosplice Announces First Patient Dosed in Phase 2 Cirtuvivint Trial
Biosplice Therapeutics has initiated a Phase 2 clinical trial of its CLK/DYRK kinase inhibitor, cirtuvivint, in patients with advanced...
OBI Pharma Announces FDA IND Clearance for Phase 1/2 Study of OBI-902, a TROP-2 Targeting ADC
OBI Pharma, a clinical-stage oncology company, received FDA clearance for an Investigational New Drug (IND) application for OBI-902, a...
Neurocrine Starts Phase 3 Trial of NBI-1117568 for Schizophrenia
Nxera Pharma’s partner, Neurocrine Biosciences, has launched a Phase 3 trial for NBI-1117568, an oral M4 selective receptor agonist,...
DecisionDx®-Melanoma Test Outperforms in Low-Risk SLN Positivity
A new study in Cancer Diagnosis & Prognosis shows that Castle Biosciences’ DecisionDx–Melanoma test outperforms current standards for identifying...
Gazya as a New Option for Lupus Nephritis
The American College of Rheumatology (ACR) updated its lupus nephritis (LN) treatment guidelines, emphasizing triple therapy with Benlysta or...
NeuroSigma’s Monarch eTNS System ADHD Trial for Children with Fetal Alcohol Syndrome at UCLA
NeuroSigma, Inc. announced a new clinical trial for its Monarch external Trigeminal Nerve Stimulation (eTNS) device. The trial will...
Oncocyte’s Promising Clinical Trial Update
Oncocyte Corporation (Nasdaq: OCX) is preparing to launch a pivotal clinical trial for its organ transplant rejection monitoring test...